Hartford Hospital

hartfordhospital.org

Total trials

103

Active

13

Phase 3

3

Total enrollment

10,081

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 11 of 11 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Liposomal bupivacaine2
Etomidate1
Propofol1
Liposomal Bupivicaine/Bupivacaine Admixture1
Bupivacaine HCL1
Bupivacaine Hcl 0.25% Inj1
Ropivacaine1
Bupivacain1
High THC/No CBD Marihuana1
High THC/High CBD Marihuana1
No THC/No CBD Marihuana1

Next readouts

  • 2025-11
  • 2025-12
  • 2026-10-30
  • 2026-12-30
  • 2026-12-30

Top conditions

  • Obesity7
  • Coronary Artery Disease5
  • Pelvic Organ Prolapse5
  • Diabetes5
  • Wound Infection4
  • Healthy Volunteers4
  • Hoarding Disorder3
  • Suicide, Attempted3

Frequently asked questions about Hartford Hospital

How many clinical trials does Hartford Hospital have on ClinicalTrials.gov?
Hartford Hospital is listed as the lead sponsor on 103 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
How many of Hartford Hospital's trials are in Phase 3?
3 of Hartford Hospital's trials are in Phase 3, spread across 11 active drug programs.
What therapeutic areas does Hartford Hospital focus on?
Hartford Hospital's most-studied conditions on ClinicalTrials.gov are Obesity, Coronary Artery Disease, Pelvic Organ Prolapse, Diabetes, Wound Infection.
When are Hartford Hospital's next clinical trial readouts?
Hartford Hospital has 5 upcoming primary-completion readouts tracked here; the soonest is “Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy”, expected around 2025-11.